Articles by Ludwig Burger | Manitoba Co-operator

Bayer considers new tactic in Roundup settlement talks

Reuters — As Bayer tries to settle U.S. lawsuits claiming that its Roundup herbicide causes cancer, the company is considering a proposal that would bar plaintiffs’ lawyers involved in the litigation from advertising for new clients, according to a person familiar with the matter. Bayer has said it is engaged in mediation to resolve the

Crops

K+S cuts output on weak potash demand

By GFM Network News, Ludwig Burger September 23, 2019

Frankfurt | Reuters — German mineral miner K+S will cut production of potash fertilizers, dragging core earnings lower, as a halt imposed by China on potash imports dampens global markets. “In the current weak market environment, which is further intensified by the continuing Chinese import bans on the standard potassium chloride product, adjusting production is

Livestock

Elanco to become No. 2 in animal health with Bayer deal

By GFM Network News, Ludwig Burger August 20, 2019

Reuters — Elanco Animal Health agreed to buy Bayer’s veterinary drugs unit on Tuesday in a cash and stock deal valued at US$7.6 billion (C$10 billion), creating the second largest maker of medicines for livestock and pets and expanding Elanco’s reach online. The deal is the latest in the fast-growing animal health market, which has

Crops

Bayer mediator dismisses report of Roundup settlement

By GFM Network News, Jonathan Stempel, Ludwig Burger August 11, 2019

New York/Frankfurt | Reuters — Bayer AG has not offered to pay billions of dollars to settle claims in the United States related to the Roundup herbicide, mediator Ken Feinberg said, dismissing a report to that effect which drove its shares as much as 11 per cent higher. “Bayer has not proposed paying $8 billion

Crops

Investors call for reprieve for Bayer bosses after AGM rebuke

By GFM Network News, Ludwig Burger April 29, 2019

Frankfurt | Reuters — Three of Bayer’s largest German investors said the drugmaker’s embattled management needed to stay at the helm to avoid further upheaval, despite their unease over a share price slump in the wake of the US$63 billion Monsanto takeover. The backing for CEO Werner Baumann comes after an unprecedented rebuke at the

Crops

Bayer shareholders vent ire over Monsanto-linked stock rout

By GFM Network News, Ludwig Burger April 26, 2019

Bonn | Reuters — Bayer shareholders vented their anger over its stock price slump on Friday as litigation risks mount from the German drugmaker’s US$63 billion takeover of seed and chemical firm Monsanto. Several large investors said they will not support aspirin invesotr Bayer’s management in a key vote scheduled for the end of its

Crops

Bayer reaps profit lift from Monsanto

By GFM Network News, Ludwig Burger February 27, 2019

Leverkusen, Germany | Reuters –– Bayer’s US$63 billion purchase of seed and chemical firm Monsanto made its mark on the German company’s fourth quarter earnings on Wednesday, lifting profit and boding well for the peak season of its enlarged agriculture business. However, mounting litigation risks related to Monsanto still cast a pall over an adjusted

Livestock

Bayer to shed animal health division, others after Monsanto deal

By GFM Network News, Ludwig Burger November 29, 2018

Frankfurt | Reuters — Bayer, the German drugmaker that bought U.S. seed company Monsanto, announced on Thursday the sale of its animal health business and a number of others, around 12,000 job cuts and 3.3 billion euros (C$4.98 billion) in impairments. CEO Werner Baumann is under pressure to boost Bayer’s share price after a drop

Crops, Markets

Ag trade flows may change amid trade dispute, Bayer says

By GFM Network News, Ludwig Burger September 18, 2018

Monheim | Reuters — Bayer said on Tuesday it would be difficult to predict 2019 earnings at its agriculture business, which now includes Monsanto, because a U.S.-Chinese trade dispute could reroute global trade flows in farming commodities. The head of Bayer’s crop science division told Reuters his company could even benefit if U.S. farmers switched

Crops

With drugs pipeline in focus, Bayer seen considering cuts

By GFM Network News, Ludwig Burger September 4, 2018

Frankfurt | Reuters — Bayer is considering job cuts and outsourcing as part of a wide-ranging review of drug research and development that will last until at least November, a person familiar with the company told Reuters. The prospect of “very tangible changes” contributed to a decision by key board members to extend the contract

Coronavirus stalls talks with China on canola ban

Fund traders still bearish on canola

U.S. grains: Soy, wheat, corn close lower after early gains

GFM Network News

Coronavirus stalls talks with China on canola ban

Fund traders still bearish on canola

U.S. grains: Soy, wheat, corn close lower after early gains

Author Archives Ludwig Burger

Bayer considers new tactic in Roundup settlement talks

K+S cuts output on weak potash demand

Elanco to become No. 2 in animal health with Bayer deal

Bayer mediator dismisses report of Roundup settlement

Investors call for reprieve for Bayer bosses after AGM rebuke

Bayer shareholders vent ire over Monsanto-linked stock rout

Bayer reaps profit lift from Monsanto

Bayer to shed animal health division, others after Monsanto deal

Ag trade flows may change amid trade dispute, Bayer says

With drugs pipeline in focus, Bayer seen considering cuts

Podcasts

Special Edition: A conversation with Marie-Claude Bibeau, Canada’s agriculture minister

AgCanadaTV

AGCanadaTV: In Case You Missed It – Your National Ag News Recap for the week ending February 21, 2020.

GFM Network News

Podcasts

AgCanadaTV

Daily Newsletter